1. Zhou, Peng, Zhang, Caiyun, Song, Xianmin, Zhu, Minhui, Zheng, Hongliang. 2022. ΔNp63α promotes Bortezomib resistance via the CYGB-ROS axis in head and neck squamous cell carcinoma. In Cell death & disease, 13, 327. doi:10.1038/s41419-022-04790-0. https://pubmed.ncbi.nlm.nih.gov/35397613/
2. Zhang, Jingcheng, Zhang, Wentao, Liu, Ji, Yao, Xudong, Yan, Yang. 2024. SOX7 inhibits the malignant progression of bladder cancer via the DNMT3B/CYGB axis. In Molecular biomedicine, 5, 36. doi:10.1186/s43556-024-00198-8. https://pubmed.ncbi.nlm.nih.gov/39227479/
3. John, Rince, Chand, Vaibhav, Chakraborty, Sankalpa, Jaiswal, Neha, Nag, Alo. 2014. DNA damage induced activation of Cygb stabilizes p53 and mediates G1 arrest. In DNA repair, 24, 107-112. doi:10.1016/j.dnarep.2014.09.003. https://pubmed.ncbi.nlm.nih.gov/25269893/
4. Hoang, Dinh Viet, Thuy, Le Thi Thanh, Hai, Hoang, Yoshizato, Katsutoshi, Kawada, Norifumi. 2022. Cytoglobin attenuates pancreatic cancer growth via scavenging reactive oxygen species. In Oncogenesis, 11, 23. doi:10.1038/s41389-022-00389-4. https://pubmed.ncbi.nlm.nih.gov/35504863/
5. Lv, Yinghui, Wang, Qizhao, Diao, Yong, Xu, Ruian. . Cytoglobin: a novel potential gene medicine for fibrosis and cancer therapy. In Current gene therapy, 8, 287-94. doi:. https://pubmed.ncbi.nlm.nih.gov/18691024/
智鼠故事 
